622 related articles for article (PubMed ID: 12495282)
21. The effect of postmenopausal hormone therapy with or without folic acid supplementation on serum homocysteine level.
Toprak A; Erenus M; Ilhan AH; Haklar G; Fak AS; Oktay A
Climacteric; 2005 Sep; 8(3):279-86. PubMed ID: 16390760
[TBL] [Abstract][Full Text] [Related]
22. Homocyst(e)ine metabolism in hemodialysis patients treated with vitamins B6, B12 and folate.
Henning BF; Zidek W; Riezler R; Graefe U; Tepel M
Res Exp Med (Berl); 2001 Mar; 200(3):155-68. PubMed ID: 11426667
[TBL] [Abstract][Full Text] [Related]
23. Vitamin B6 metabolism and homocysteine in end-stage renal disease and chronic renal insufficiency.
Lindner A; Bankson DD; Stehman-Breen C; Mahuren JD; Coburn SP
Am J Kidney Dis; 2002 Jan; 39(1):134-45. PubMed ID: 11774112
[TBL] [Abstract][Full Text] [Related]
24. Uremic hyperhomocysteinemia: a randomized trial of folate treatment for the prevention of cardiovascular events.
Vianna AC; Mocelin AJ; Matsuo T; Morais-Filho D; Largura A; Delfino VA; Soares AE; Matni AM
Hemodial Int; 2007 Apr; 11(2):210-6. PubMed ID: 17403173
[TBL] [Abstract][Full Text] [Related]
25. [Efficacy and safety of two vitamin supplement regimens on homocysteine levels in hemodialysis patients. Prospective, randomized clinical trial].
Sánchez Alvarez JE; Pérez Tamajón L; Hernández D; Alvarez González A; Delgado P; Lorenzo V
Nefrologia; 2005; 25(3):288-96. PubMed ID: 16053010
[TBL] [Abstract][Full Text] [Related]
26. The evaluation of postdialysis L-carnitine administration and its effect on weekly requiring doses of rHuEPO in hemodialysis patients.
Kadiroglu AK; Yilmaz ME; Sit D; Kara IH; Isikoglu B
Ren Fail; 2005; 27(4):367-72. PubMed ID: 16060121
[TBL] [Abstract][Full Text] [Related]
27. Different doses of oral folic acid for homocysteine-lowering therapy in patients on hemodialysis: a randomized controlled trial.
Ossareh S; Shayan-Moghaddam H; Salimi A; Asgari M; Farrokhi F
Iran J Kidney Dis; 2009 Oct; 3(4):227-33. PubMed ID: 19841527
[TBL] [Abstract][Full Text] [Related]
28. Folate supplementation does not affect biochemical markers of bone turnover.
Herrmann M; Stanger O; Paulweber B; Hufnagl C; Herrmann W
Clin Lab; 2006; 52(3-4):131-6. PubMed ID: 16584059
[TBL] [Abstract][Full Text] [Related]
29. Homocysteine-lowering vitamin B treatment decreases cardiovascular events in hemodialysis patients.
Righetti M; Serbelloni P; Milani S; Ferrario G
Blood Purif; 2006; 24(4):379-86. PubMed ID: 16755160
[TBL] [Abstract][Full Text] [Related]
30. Betaine as a determinant of postmethionine load total plasma homocysteine before and after B-vitamin supplementation.
Holm PI; Bleie Ø; Ueland PM; Lien EA; Refsum H; Nordrehaug JE; Nygård O
Arterioscler Thromb Vasc Biol; 2004 Feb; 24(2):301-7. PubMed ID: 14699020
[TBL] [Abstract][Full Text] [Related]
31. [Hyperhomocysteinemia and alternate vitamin supplementation].
De Angelis S; Noce A; Dessì M; Pastore A; Scaccia F; Trombetta M; Tozzo C; Splendiani G
G Ital Nefrol; 2007; 24(1):51-5. PubMed ID: 17342693
[TBL] [Abstract][Full Text] [Related]
32. Homocysteine, vitamin B12, serum and erythrocyte folate in peritoneal dialysis patients.
De Vecchi AF; Bamonti-Catena F; Finazzi S; Patrosso C; Taioli E; Novembrino C; Colucci P; Lando G; De Franceschi M; Marocchi A; Maiolo AT
Clin Nephrol; 2001 Apr; 55(4):313-7. PubMed ID: 11334318
[TBL] [Abstract][Full Text] [Related]
33. Assessment of three levels of folic acid on serum folate and plasma homocysteine: a randomised placebo-controlled double-blind dietary intervention trial.
Venn BJ; Mann JI; Williams SM; Riddell LJ; Chisholm A; Harper MJ; Aitken W; Rossaak JI
Eur J Clin Nutr; 2002 Aug; 56(8):748-54. PubMed ID: 12122551
[TBL] [Abstract][Full Text] [Related]
34. Cobalamin dose regimen for maximum homocysteine reduction in end-stage renal disease.
Hoffer LJ; Saboohi F; Golden M; Barré PE
Metabolism; 2005 Jun; 54(6):835-40. PubMed ID: 15931623
[TBL] [Abstract][Full Text] [Related]
35. [Frequency of hyperhomocysteinemia in hemodialysis patients with folic acid supplementation].
Kárpáti I; Balla J; Szóke G; Bereczky Z; Páll D; Ben T; Toma K; Katona E; Mohácsi A; Paragh G; Varga Z; Kakuk G; Muszbek L
Orv Hetil; 2002 Jul; 143(27):1635-40. PubMed ID: 12180000
[TBL] [Abstract][Full Text] [Related]
36. The achievement of normal homocysteinemia in regular extracorporeal dialysis patients.
Gonella M; Calabrese G; Mengozzi A; Aleo AG; Vagelli G; Mazzotta A; Deambrogio P
J Nephrol; 2004; 17(3):411-3. PubMed ID: 15365962
[TBL] [Abstract][Full Text] [Related]
37. Folate and cobalamin synergistically decrease the risk of high plasma homocysteine in a nonsupplemented elderly institutionalized population.
Huerta JM; González S; Vigil E; Prada M; San Martín J; Fernández S; Patterson AM; Lasheras C
Clin Biochem; 2004 Oct; 37(10):904-10. PubMed ID: 15369722
[TBL] [Abstract][Full Text] [Related]
38. Vitamin B12 decreases, but does not normalize, homocysteine and methylmalonic acid in end-stage renal disease: a link with glycine metabolism and possible explanation of hyperhomocysteinemia in end-stage renal disease.
Hyndman ME; Manns BJ; Snyder FF; Bridge PJ; Scott-Douglas NW; Fung E; Parsons HG
Metabolism; 2003 Feb; 52(2):168-72. PubMed ID: 12601627
[TBL] [Abstract][Full Text] [Related]
39. Relationships between homocysteine and related amino acids in chronic hemodialysis patients.
McDonald SP; Whiting MJ; Tallis GA; Barbara JA
Clin Nephrol; 2001 Jun; 55(6):465-70. PubMed ID: 11434358
[TBL] [Abstract][Full Text] [Related]
40. The effect of mesna on plasma total homocysteine concentration in hemodialysis patients.
Urquhart BL; Freeman DJ; Spence JD; House AA
Am J Kidney Dis; 2007 Jan; 49(1):109-17. PubMed ID: 17185151
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
